A Randomised, Open-label, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of AZD1775 After Oral Dosing of a Capsule Formulation in Patients With Advanced Solid Tumours
Phase of Trial: Phase I
Latest Information Update: 03 May 2018
At a glance
- Drugs Adavosertib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 27 Apr 2018 Status changed from active, no longer recruiting to completed.
- 22 Mar 2018 Planned End Date changed from 5 Apr 2018 to 12 Apr 2018.
- 22 Mar 2018 Planned primary completion date changed from 5 Apr 2018 to 12 Apr 2018.